Literature DB >> 33582609

Type 3 secretion system of Pseudomonas aeruginosa.

Gertrudis Horna1, Joaquim Ruiz2.   

Abstract

Pseudomonas aeruginosa is an opportunistic pathogen, mainly affecting severe patients, such as those in intensive care units (ICUs). High levels of antibiotic resistance and a long battery of virulence factors characterise this pathogen. Among virulence factors, the T3SS (Type 3 Secretion Systems) are especially relevant, being one of the most important virulence factors in P. aeruginosa. T3SS are a complex "molecular syringe" able to inject different effectors in host cells, subverting cell machinery influencing immune responses, and increasing bacterial survival rates. While T3SS have been largely studied and the molecular structure and main effector functions have been established, a series of questions and further points remain to be clarified or established. The key role of T3SS in P. aeruginosa virulence has resulted in the search for T3SS-targeting molecules able to impair their functions and subsequently improve patient outcomes. This review aims to summarise the most relevant features of the P. aeruginosa T3SS.
Copyright © 2021 Elsevier GmbH. All rights reserved.

Entities:  

Keywords:  Pathogenicity; Pseudomonas aeruginosa; Virulence

Year:  2021        PMID: 33582609     DOI: 10.1016/j.micres.2021.126719

Source DB:  PubMed          Journal:  Microbiol Res        ISSN: 0944-5013            Impact factor:   5.415


  11 in total

Review 1.  A comprehensive review on genomics, systems biology and structural biology approaches for combating antimicrobial resistance in ESKAPE pathogens: computational tools and recent advancements.

Authors:  P Priyamvada; Reetika Debroy; Anand Anbarasu; Sudha Ramaiah
Journal:  World J Microbiol Biotechnol       Date:  2022-07-05       Impact factor: 3.312

Review 2.  Anti-bacterial monoclonal antibodies: next generation therapy against superbugs.

Authors:  Hui Wang; Daijie Chen; Huili Lu
Journal:  Appl Microbiol Biotechnol       Date:  2022-06-01       Impact factor: 4.813

Review 3.  Pseudomonas aeruginosa: pathogenesis, virulence factors, antibiotic resistance, interaction with host, technology advances and emerging therapeutics.

Authors:  Shugang Qin; Wen Xiao; Chuanmin Zhou; Qinqin Pu; Xin Deng; Lefu Lan; Haihua Liang; Xiangrong Song; Min Wu
Journal:  Signal Transduct Target Ther       Date:  2022-06-25

Review 4.  Virulence Factors of Pseudomonas Aeruginosa and Antivirulence Strategies to Combat Its Drug Resistance.

Authors:  Chongbing Liao; Xin Huang; Qingxia Wang; Dan Yao; Wuyuan Lu
Journal:  Front Cell Infect Microbiol       Date:  2022-07-06       Impact factor: 6.073

5.  The Phenomenon of T3SS Inactivation for Pseudomonas aeruginosa Strains from a Chronic Infection Locus: Do Mutations in T3SS-Regulators Matter?

Authors:  T Savinova; Y Bocharova; N Mayanskiy; I Chebotar
Journal:  Microbiol Spectr       Date:  2022-05-16

Review 6.  The Epidemiology and Pathogenesis and Treatment of Pseudomonas aeruginosa Infections: An Update.

Authors:  Dan Reynolds; Marin Kollef
Journal:  Drugs       Date:  2021-11-07       Impact factor: 9.546

Review 7.  The Regulatory Hierarchy Following Signal Integration by the CbrAB Two-Component System: Diversity of Responses and Functions.

Authors:  Elizabet Monteagudo-Cascales; Eduardo Santero; Inés Canosa
Journal:  Genes (Basel)       Date:  2022-02-18       Impact factor: 4.096

Review 8.  The Role of Pseudomonas aeruginosa Virulence Factors in Cytoskeletal Dysregulation and Lung Barrier Dysfunction.

Authors:  Brant M Wagener; Ruihan Hu; Songwei Wu; Jean-Francois Pittet; Qiang Ding; Pulin Che
Journal:  Toxins (Basel)       Date:  2021-11-02       Impact factor: 5.075

Review 9.  Using Structure-guided Fragment-Based Drug Discovery to Target Pseudomonas aeruginosa Infections in Cystic Fibrosis.

Authors:  Sheikh Mohammed Arif; R Andres Floto; Tom L Blundell
Journal:  Front Mol Biosci       Date:  2022-03-30

10.  Immunogenicity and Protective Capacity of a Virus-like Particle Vaccine against Chlamydia trachomatis Type 3 Secretion System Tip Protein, CT584.

Authors:  Everett Webster; Kyra W Seiger; Susan B Core; Amanda L Collar; Hannah Knapp-Broas; June Graham; Muskan Shrestha; Sarah Afzaal; William M Geisler; Cosette M Wheeler; Bryce Chackerian; Kathryn M Frietze; Rebeccah S Lijek
Journal:  Vaccines (Basel)       Date:  2022-01-12
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.